Atlas Principals’s Bristol-Myers Squibb BMY Stock Holding History

Atlas Principals’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-35,528	Closed	-$1.98M	–	40
2020 Q1	$1.98M	Buy	+35,528	New	+$2.17M	1.88%	15

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Atlas Principals's BMY Position: Q2 2020 in Review

Atlas Principals sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 35,528 shares — an estimated $1.98M sold.

Atlas Principals first reported a position in BMY in Q1 2020 and held it in 1 quarter. The position peaked at $1.98M in Q1 2020. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

Atlas Principals reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
Atlas Principals sold 35,528 Bristol-Myers Squibb shares in Q2 2020, an estimated $1.98M.
Atlas Principals first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 1 quarter.
Atlas Principals's Bristol-Myers Squibb position peaked at $1.98M in Q1 2020.
2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Atlas Principals's 13F filing for Q2 2020, filed 14 Aug 2020.